
Sign up to save your podcasts
Or


It's the story Becky Quick never thought she would tell. Her own.
As a mom to a child with a rare genetic disease, Squawk Box co-host Becky Quick dove into the hidden world of the many ways biological chance can change our lives. Thirty million Americans have a rare disease, which impact small numbers of patients. Two-thirds of those thirty million are children; 95% of rare diseases don’t have an FDA-approved treatment. But despite those eye-popping numbers, millions of people continue to suffer from diseases that often go overlooked by the broader healthcare industry. Small patient populations mean drug companies and investors aren’t willing to invest in the space, and outdated regulatory frameworks make the process of developing lifesaving treatments too slow for the families that need them.
Becky and her husband Matt Quayle share the journey of their 9-year old daughter Kaylie, who has a rare genetic condition called SYNGAP-1. Over the next several episodes of The Path, Becky will highlight the unique challenges faced by millions of Americans, put a spotlight on the bottlenecks slowing progress in the rare disease space, and talk with stakeholders who have the power to bring about change.
Join us in advancing awareness and understanding of rare diseases. Visit CNBC.com/Cures to access clips, resources, or to sign up for our weekly newsletter.
Follow Becky Quick on X: @BeckyQuick
Please share your thoughts or rare disease story in the comments, and join us on The Path.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
526526 ratings
It's the story Becky Quick never thought she would tell. Her own.
As a mom to a child with a rare genetic disease, Squawk Box co-host Becky Quick dove into the hidden world of the many ways biological chance can change our lives. Thirty million Americans have a rare disease, which impact small numbers of patients. Two-thirds of those thirty million are children; 95% of rare diseases don’t have an FDA-approved treatment. But despite those eye-popping numbers, millions of people continue to suffer from diseases that often go overlooked by the broader healthcare industry. Small patient populations mean drug companies and investors aren’t willing to invest in the space, and outdated regulatory frameworks make the process of developing lifesaving treatments too slow for the families that need them.
Becky and her husband Matt Quayle share the journey of their 9-year old daughter Kaylie, who has a rare genetic condition called SYNGAP-1. Over the next several episodes of The Path, Becky will highlight the unique challenges faced by millions of Americans, put a spotlight on the bottlenecks slowing progress in the rare disease space, and talk with stakeholders who have the power to bring about change.
Join us in advancing awareness and understanding of rare diseases. Visit CNBC.com/Cures to access clips, resources, or to sign up for our weekly newsletter.
Follow Becky Quick on X: @BeckyQuick
Please share your thoughts or rare disease story in the comments, and join us on The Path.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,085 Listeners

1,355 Listeners

240 Listeners

154 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

326 Listeners

67 Listeners

154 Listeners

294 Listeners

33 Listeners

45 Listeners

2,149 Listeners

1,302 Listeners

586 Listeners

5 Listeners

20 Listeners

1,561 Listeners

213 Listeners

410 Listeners

300 Listeners

119 Listeners

825 Listeners

171 Listeners

34 Listeners

10 Listeners

29 Listeners

9 Listeners

16 Listeners

2 Listeners